Bruker (BRKR) Net Cash Flow Growth (1y) (2011 - 2026)
Powered by 
Analysis
Bruker (BRKR) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 226.93 Bn | 222.99 Bn | 8.34 Bn | 498.33% |
| 2 | Danaher | 145.94 Bn | 141.60 Bn | 3.61 Bn | -260.86% |
| 3 | Agilent Technologies | 42.55 Bn | 40.79 Bn | 1.04 Bn | -189.36% |
| 4 | Illumina | 32.95 Bn | 31.78 Bn | 770.00 Mn | 73.12% |
| 5 | Revvity | 14.53 Bn | 13.51 Bn | 416.87 Mn | 188.37% |
| 6 | Bio-Techne | 11.31 Bn | 11.04 Bn | 211.39 Mn | 576.28% |
| 7 | Bio-Rad Laboratories | 10.34 Bn | 8.72 Bn | 345.80 Mn | 103.25% |
| 8 | Repligen | 9.46 Bn | 8.44 Bn | 110.04 Mn | 130.07% |
| 9 | Bruker | 8.91 Bn | 8.73 Bn | 416.00 Mn | 137.77% |
| 10 | 10x Genomics | 8.16 Bn | 7.61 Bn | 112.50 Mn | -39.60% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 137.77% |
| Mar 31, 2026 | -1,309.76% |
| Dec 31, 2025 | -87.68% |
| Sep 30, 2025 | 731.35% |
| Jun 30, 2025 | 26.73% |
| Mar 31, 2025 | 90.59% |
| Dec 31, 2024 | -50.00% |
| Sep 30, 2024 | 84.32% |
| Jun 30, 2024 | -621.03% |
| Mar 31, 2024 | -154.28% |
| Dec 31, 2023 | 882.73% |
| Sep 30, 2023 | -190.16% |
| Jun 30, 2023 | 65.28% |
| Mar 31, 2023 | 78.71% |
| Dec 31, 2022 | -102.81% |
| Sep 30, 2022 | -158.67% |
| Jun 30, 2022 | 28.92% |
| Mar 31, 2022 | -772.42% |
| Dec 31, 2021 | 394.79% |
| Sep 30, 2021 | 85.83% |